SIC 2834 – Pharmaceutical Preparations
| Valuation | |
|---|---|
| Market Cap ($M) | 1,497.67 |
| Enterprise Value ($M) | 1,310.94 |
| Book Value ($M) | 336.68 |
| Book Value / Share | 5.78 |
| Price / Book | 4.45 |
| NCAV ($M) | 334.30 |
| NCAV / Share | 5.74 |
| Price / NCAV | 4.48 |
| Profitability (mra) | |
|---|---|
| Return on Invested Capital (ROIC) | -0.23 |
| Return on Assets (ROA) | -0.33 |
| Return on Equity (ROE) | -0.37 |
| Liquidity (mrq) | |
|---|---|
| Quick Ratio | 16.71 |
| Current Ratio | 16.71 |
| Balance Sheet (mrq) ($M) | |
|---|---|
| Current Assets | 355.58 |
| Assets | 357.95 |
| Liabilities | 21.27 |
| Debt | n/a |
| Equity | n/a |
| Income Statement (mra) ($M) | |
|---|---|
| Revenue | 60.00 |
| Operating Income | -93.65 |
| Net Income | -78.95 |
| Earnings Per Share Basic And Diluted | n/a |
| Cash Flow Statement (mra) ($M) | |
|---|---|
| Cash From Operations | -70.24 |
| Cash from Investing | -39.26 |
| Cash from Financing | 170.48 |
(click for more detail) |
|
| File Date | Form | Activist 13D/G Investors | Ownership (%) |
Change (%) |
|---|---|---|---|---|
| 13G/A | Point72 Asset Management, L.P. | 4.50 | -17.97 | |
| 13G/A | Citadel Advisors Llc | 0.70 | ||
| 13G/A | Rtw Investments, Lp | 9.20 | 47.98 | |
| 13G/A | Biotechnology Value Fund L P | 9.99 | 14.68 | |
| 13G/A | Vanguard Group Inc | 5.47 | 1.81 | |
| 13G/A | Adage Capital Partners Gp, L.l.c. | 2.24 | -56.29 | |
| 13G/A | Farallon Capital Partners, L.P. | 9.99 | 14.05 | |
| 13G/A | BlackRock Inc. | 9.60 | 51.80 | |
| 13G/A | State Street Corp | 4.73 | -28.03 |
| Top 13F Investors | Shares (1000) |
Change (%) |
Value ($1000) |
Change (%) |
|---|---|---|---|---|
(click for more detail) |
||||
| Date | Insider Trades | Code | Shares | Value |
|---|---|---|---|---|
(click for more detail) |
||||
| File Date | Form | SEC Filings |
|---|---|---|
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q | ||
(click for more detail) |
||
| Short Volume | |||
|---|---|---|---|
| Market Date | Short Volume | Total Volume | Short Volume Ratio |
| 76,485 | 394,743 | 19.38 | |
| 54,853 | 234,042 | 23.44 | |
| 44,291 | 239,554 | 18.49 | |
| 41,780 | 138,910 | 30.08 | |
(click for more detail) |
|||
| Similar Companies | |
|---|---|
| OMER – Omeros Corporation | PAHC – Phibro Animal Health Corporation |
| PROC – Procaps Group S.A. | PWUP – PowerUp Acquisition Corp. |
| QTTB – Q32 Bio Inc. |
Financial data and stock pages provided by
Fintel.io